Ticketplus updates 1.9M-share prospectus with results

Ticketplus Ltd. (TP) filed Prospectus Supplement No. 1 to its August 6, 2026 prospectus covering 1,875,000 Ordinary Shares registered under its Form F-1.

Rhea-AI Filing Summary

Ticketplus Ltd. (TP) filed Prospectus Supplement No. 1 to its August 6, 2026 prospectus covering 1,875,000 Ordinary Shares registered under its Form F-1. The supplement adds information from a Form 6-K furnishing unaudited interim consolidated financial statements and an operating and financial review for the six months ended June 30, 2026 and 2025.

The Ordinary Shares trade on NYSE American under the symbol TP, with a $7.10 closing price on August 19, 2026. Ticketplus is identified as both an emerging growth company and a foreign private issuer, and highlights that investing in its securities involves a high degree of risk as described in its prospectus risk factors.

Filing Explained

Beyond updating the F-1 prospectus with the furnished Form 6-K, Ticketplus states that the 6-K and Exhibits 99.1 and 99.2 are incorporated into its S-8 registration statement from the date the report was furnished, August 19, 2026.

Key Figures

Registered Shares: 1,875,000 Ordinary Shares Closing Share Price: $7.10 Prospectus Date: August 6, 2026 +2 more

5 metrics

Registered Shares 1,875,000 Ordinary Shares Amount covered by the August 6, 2026 prospectus referenced in Prospectus Supplement No. 1

Closing Share Price $7.10 Closing price of Ordinary Shares on NYSE American on August 19, 2026

Prospectus Date August 6, 2026 Date of the base prospectus for Ticketplus Ltd.’s Form F-1

Prospectus Supplement Date August 20, 2026 Date of Prospectus Supplement No. 1

Exchange Act File Number 001-43438 Commission file number for Ticketplus Ltd. as a foreign private issuer

Key Terms

Prospectus Supplement, emerging growth company, foreign private issuer, Form 6-K, +1 more

5 terms

Prospectus Supplement regulatory

"This Prospectus Supplement No. 1 is being filed to include the information"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

emerging growth company regulatory

"We are an “emerging growth company” under applicable federal securities laws"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

foreign private issuer regulatory

"We are a “foreign private issuer” under applicable federal securities laws"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Form 6-K regulatory

"Ticketplus Ltd. is furnishing this Form 6-K to provide the unaudited"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

forward-looking statements regulatory

"This Report on Form 6-K contains forward-looking statements and information"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Offering Details

IPO

Offering

Offering Type IPO

FAQ

What does Ticketplus Ltd. (TP) register in this Prospectus Supplement No. 1?

Ticketplus Ltd. updates its August 6, 2026 prospectus for 1,875,000 Ordinary Shares by incorporating a new Form 6-K. The Form 6-K provides unaudited interim consolidated financial statements and an operating and financial review for the six months ended June 30, 2026 and 2025.

What new information is added for Ticketplus Ltd. (TP) investors in this filing?

The filing adds a Form 6-K containing unaudited interim consolidated financial statements and an operating and financial review for the six months ended June 30, 2026 and 2025. These disclosures are incorporated into Ticketplus’s existing registration statements, including its Form S-8 and Form F-1 prospectus.

On which exchange are Ticketplus Ltd. (TP) shares traded and at what recent price?

Ticketplus Ltd.’s Ordinary Shares trade on NYSE American under the symbol TP. On August 19, 2026, the closing price was $7.10 per share, providing a recent market reference for the company’s equity as described in the supplement.

How does Ticketplus Ltd. (TP) classify itself under U.S. securities laws?

Ticketplus Ltd. is classified as both an emerging growth company and a foreign private issuer. This status allows it to follow certain reduced public company reporting requirements in its prospectus and future SEC filings compared with larger, more seasoned U.S. issuers.

Which other registration statement does the Ticketplus Ltd. (TP) Form 6-K affect?

The Form 6-K, including Exhibit 99.1, is incorporated into Ticketplus Ltd.’s Form S-8 registration statement (File No. 333-298180). It becomes part of that registration from the furnishing date, unless superseded by later filings under the Securities Act or Exchange Act.

What period do Ticketplus Ltd. (TP)’s newly furnished financial statements cover?

The newly furnished unaudited interim consolidated financial statements cover as of June 30, 2026 and the six months ended June 30, 2026 and 2025. They are accompanied by an operating and financial review and prospects discussion for those interim periods.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 07:04 AM Accepted by SEC EDGAR 08/20/2026 - 07:00 AM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-296318

Prospectus Supplement No. 1 to Prospectus dated August 6, 2026

Ticketplus Ltd.

1,875,000 Ordinary Shares

This Prospectus Supplement No. 1 (“Prospectus Supplement No. 1”) relates to the Prospectus of Ticketplus Ltd. (“we,” “us,” or “our”), dated August 6, 2026 (the “Prospectus”), filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, which forms a part of our Registration Statement on Form F-1, as amended (Registration No. 333-296318). Capitalized terms used in this Prospectus Supplement No. 1 and not otherwise defined herein have the meanings specified in the Prospectus.

This Prospectus Supplement No. 1 is being filed to include the information in our Report on Form 6-K which was furnished to the Securities and Exchange Commission on August 19, 2026.

This Prospectus Supplement No. 1 should be read in conjunction with the Prospectus and is qualified by reference to the Prospectus, except to the extent that the information in this Prospectus Supplement No. 1 supersedes the information contained in the Prospectus, and may not be delivered without the Prospectus.

Our Ordinary Shares are traded under the symbol “TP” on NYSE American. On August 19, 2026, the closing price of our Ordinary Shares on NYSE American was $7.10.

We are an “emerging growth company” under applicable federal securities laws and as such, we have elected to comply with certain reduced public company reporting requirements for the Prospectus and future filings.

We are a “foreign private issuer” under applicable federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements for the Prospectus and future filings.

INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CAREFULLY READ AND CONSIDER THE “RISK FACTORS” BEGINNING ON PAGE 10 OF THE PROSPECTUS.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this Prospectus Supplement No. 1 is August 20, 2026.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number: 001-43438

TICKETPLUS LTD.

(Translation of registrant’s name into English)

Alonso de Córdova 5320, Piso 16

Las Condes, Región Metropolitana

Santiago, Chile

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒            Form 40-F ☐

EXPLANATORY NOTE

Ticketplus Ltd. (the “Company”) is furnishing this Form 6-K to provide the unaudited interim consolidated financial statements for the six months ended June 30, 2026 and 2025, including the operating and financial review and prospects for the period presented therein, and to incorporate such financial statements into the Company’s registration statement referenced below.

This Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the registration statement of the Company on Form S-8 (File No. 333-298180) and shall be a part thereof from the date on which this report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

FORWARD-LOOKING INFORMATION

This Report on Form 6-K contains forward-looking statements and information that are based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates. When used in this report, the words “may”, “will”, “anticipate”, “believe”, “estimate”, “expect”, “intend”, “plan” and similar expressions, as they relate to the Company and its management, are intended to identify forward-looking statements. These statements reflect management’s current view of the Company concerning future events and are subject to certain risks, uncertainties and assumptions, including among many others: its goals and strategies, its future business development, financial condition and results of operations, expected changes in its revenue, costs or expenditure, its expectations regarding demand for and market acceptance of our products and services, competition in its industry, government policies and regulations relating to its industry, and other risks and uncertainties which are generally set forth under the heading “Risk Factors” and elsewhere in the Company’s SEC filings. Should any of these risks or uncertainties materialize, or should the underlying assumptions about the Company’s business and the markets in which it operates prove incorrect, actual results may vary materially from those described as anticipated, estimated or expected in this report.

All forward-looking statements included herein attributable to the Company or other parties or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Except to the extent required by applicable laws and regulations, the Company undertakes no obligations to update these forward-looking statements to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events.

Exhibit No.		Description
99.1		Unaudited Interim Consolidated Financial Statements as of June 30, 2026 and for the Six Months Ended June 30, 2026 and 2025
99.2		Operating and Financial Review and Prospects in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended June 30, 2026

1

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 19, 2026	TICKETPLUS LTD.
	By:	/s/ Chien-Fu Chen Chen
		Chien-Fu Chen Chen
		Chief Executive Officer

2